Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Paushak Ltd (PAUSHAKLTD) Share Price & Fundamentals

Company Overview

Founded Year

1972

Listed Year

-

Headquarter

Vadodara, Gujarat, India

MD/CEO

Mr. Abhijit Joshi

Website

https://www.paushak.com

Company Facts

What we do

Paushak Limited is India's largest manufacturer of phosgene-based specialty chemicals such as isocyanates and chloroformates, serving diverse industries including pesticides and pharmaceuticals.

Founded in

1,972

Market share

Largest phosgene-based specialty chemical manufacturer in India with global benchmark operations.

Problem solved

Provides critical specialty chemicals used in manufacturing of pesticides, pharmaceuticals, plastics, dyes, and perfumeries.

Top clients or who we serve

Serves B2B clients in pesticides, pharmaceuticals, plastics, dyes, and perfumery industries.

Key management

Mr. Abhijit Joshi (CEO & Whole-time Director), Ms. Kirti Shah (CFO), Mr. Sagar Gandhi (Company Secretary)

Our journey and innovations

Operating since 1979 with over 55 years expertise in phosgene and derivatives; equipped with advanced R&D and safe handling practices at Panchmahal site.

Where we operate

Domestic market in India and export markets outside India, total revenue split approx. 89% India, 11% outside India.

Top products or what we offer

Phosgene gas, isocyanates, chloroformates, carbamoyl chlorides, carbamates, urea derivatives and related specialty chemicals.

Top brands

-

Raw materials needed

Phosgene gas, intermediate chemicals for specialty chemical synthesis.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily recurring from specialty chemical manufacturing and contract toll production.

Our industry position

Market leader in phosgene-based specialty chemicals in India with strong operational safety and quality systems.

Financial highlights

FY23-24 revenue: Rs 210.95 crore; net profit: Rs 49.38 crore; EBITDA around Rs 84.98 crore; consistent profitability and dividend payouts.

Geographical revenue split

Approximately 89% revenue from India and 11% from international markets as of FY23-24.

Order book

-

Whats driving growth

Growth fueled by steady demand in agrochemicals, pharmaceuticals, industry-safe production capabilities, and strategic R&D.

Our future plans

Focus on capacity optimization, innovation in specialty chemicals, maintaining safety standards, and expanding customer base.

Our green promise

Operates a 'Responsible Care' certified plant with emphasis on environment, health and safety (EHS) practices.

Our people and values

Employs over 200 skilled employees fostering safe, disciplined culture aligned with longstanding parent group values.

Key challenges ahead

Managing phosgene safety risks, regulatory compliance, and mitigating market fluctuations in specialty chemicals.

Interesting facts

Part of Alembic Group with over 115 years legacy; India's oldest pharmaceutical group origin since 1907.

Risks and strategy

Focused on risk management via board committees; mitigation includes stringent EHS policies and diversified product applications.

Market Footprint

Top Clients

Top Clients

Serves B2B clients in pesticides, pharmaceuticals, plastics, dyes, and perfumery industries.

Top Products

Top Products

Phosgene gas, isocyanates, chloroformates, carbamoyl chlorides, carbamates, urea derivatives and related specialty chemicals.

Price Movement & Share Holding

Today's High/Low

600628

52 Week High/Low

342.5881.95
Past Returns

1 week

-5.38%

1 month

-6.51%

3 month

5.24%

1 year

-12.14%

3 year

-18.93%

5 year

-51.9%

Share Holding

Promoters

67.28%

FII

0.11%

DII

0.27%

Retail

23.74%

Others

8.6%

Company Overview

Founded Year

1972

Listed Year

-

Headquarter

Vadodara, Gujarat, India

MD/CEO

Mr. Abhijit Joshi (CEO & Whole-time Director)

Website

https://www.paushak.com

Price Movement & Share Holding

Today's High/Low

600628

52 Week High/Low

342.5881.95

Past Returns

1 week

-5.38%

1 month

-6.51%

3 month

5.24%

1 year

-12.14%

3 year

-18.93%

5 year

-51.9%

Share Holding

Promoters

67.28%

FII

0.11%

DII

0.27%

Retail

23.74%

Others

8.6%

Company Facts

What we do

Paushak Limited is India's largest manufacturer of phosgene-based specialty chemicals such as isocyanates and chloroformates, serving diverse industries including pesticides and pharmaceuticals.

Founded in

1972

Market share

Largest phosgene-based specialty chemical manufacturer in India with global benchmark operations.

Problem solved

Provides critical specialty chemicals used in manufacturing of pesticides, pharmaceuticals, plastics, dyes, and perfumeries.

Top clients or who we serve

Serves B2B clients in pesticides, pharmaceuticals, plastics, dyes, and perfumery industries.

Key management

Mr. Abhijit Joshi (CEO & Whole-time Director), Ms. Kirti Shah (CFO), Mr. Sagar Gandhi (Company Secretary)

Our journey and innovations

Operating since 1979 with over 55 years expertise in phosgene and derivatives; equipped with advanced R&D and safe handling practices at Panchmahal site.

Where we operate

Domestic market in India and export markets outside India, total revenue split approx. 89% India, 11% outside India.

Top products or what we offer

Phosgene gas, isocyanates, chloroformates, carbamoyl chlorides, carbamates, urea derivatives and related specialty chemicals.

Raw materials needed

Phosgene gas, intermediate chemicals for specialty chemical synthesis.

Recurring vs cyclical contribution

Revenue primarily recurring from specialty chemical manufacturing and contract toll production.

Our industry position

Market leader in phosgene-based specialty chemicals in India with strong operational safety and quality systems.

Financial highlights

FY23-24 revenue: Rs 210.95 crore; net profit: Rs 49.38 crore; EBITDA around Rs 84.98 crore; consistent profitability and dividend payouts.

Geographical revenue split

Approximately 89% revenue from India and 11% from international markets as of FY23-24.

Whats driving growth

Growth fueled by steady demand in agrochemicals, pharmaceuticals, industry-safe production capabilities, and strategic R&D.

Our future plans

Focus on capacity optimization, innovation in specialty chemicals, maintaining safety standards, and expanding customer base.

Our green promise

Operates a 'Responsible Care' certified plant with emphasis on environment, health and safety (EHS) practices.

Our people and values

Employs over 200 skilled employees fostering safe, disciplined culture aligned with longstanding parent group values.

Key challenges ahead

Managing phosgene safety risks, regulatory compliance, and mitigating market fluctuations in specialty chemicals.

Interesting facts

Part of Alembic Group with over 115 years legacy; India's oldest pharmaceutical group origin since 1907.

Risks and strategy

Focused on risk management via board committees; mitigation includes stringent EHS policies and diversified product applications.

Market Footprint

Top Clients

Top Clients

Serves B2B clients in pesticides, pharmaceuticals, plastics, dyes, and perfumery industries.

Top Products

Top Products

Phosgene gas, isocyanates, chloroformates, carbamoyl chlorides, carbamates, urea derivatives and related specialty chemicals.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions